Treatment progress of chronic lymphocytic leukemia

VernacularTitle:慢性淋巴细胞白血病治疗进展
Author: Jingran GUO ¹ ; Wei XU
Author Information

1. 南京医科大学第一附属医院　江苏省人民医院血液科，南京　210029
Keywords: Leukemia, lymphocytic, chronic, B-cell; Molecular targeted therapy; Drug therapy, combination
From: Journal of Leukemia & Lymphoma 2021;30(6):321-324
CountryChina
Language:Chinese
Abstract: Chronic lymphocytic leukemia (CLL) is a kind of B-cell chronic lymphoproliferative disease. At present, the common clinical treatment regimens (such as FCR, BR, ibrutinib, etc.) have showed good therapeutic effects, but recurrence and progression still occur in some patients. In order to further improve the efficacy, the new combination therapies for CLL are continuously emerging. This article summarizes the treatment progress of CLL in combination with the related reports at the 62nd American Society of Hematology Annual Meeting.